The abstract is read at the publisher; the summary is JClub's.
GPR18 signaling in pancreatic islet macrophages is linked to a CD36-dependent Gq/AMPK pathway that remodels sphingolipid metabolism and reduces insulin secretion from β cells.
- Why it matters: Islet macrophages regulate β cell activity in obesity-associated type 2 diabetes, but the specific receptor and signaling route connecting macrophages to β cells remained unclear.
- What they did: Singh et al. used chemogenetics to identify a Gq/AMPK pathway controlling sphingolipid metabolism, then mapped macrophage-to-β cell communication to a CD36-dependent mechanism involving GPR18.
- The result: The study identifies GPR18 as the receptor that engages this immunometabolic pathway, expanding macrophage–β cell communication models and suggesting GPR18 as a potential therapeutic target for type 2 diabetes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.